Cite

    Xu, G., Gaul, M. D., Liu, Z., DesJarlais, R. L., Qi, J., Wang, W., Krosky, D., Petrounia, I., Milligan, C. M., Hermans, A., Lu, H., Huang, D. Z., Xu, J. Z., & Spurlino, J. C. (2020). hit-to-lead optimization and discovery of a potent, and orally bioavailable G protein coupled receptor kinase 2 (GRK2) inhibitor. Bioorganic & medicinal chemistry letters, 30(23), . http://access.bl.uk/ark:/81055/vdc_100115122362.0x00001f